Save the Date: June 25, 2025
Advancing Neuroscience: Breakthroughs in Biomarker Discovery and Preclinical Development for Neurological Diseases
- days
- Hours
- Minutes
- Seconds
You're Invited!
You are invited to a complimentary neuroscience symposium in South San Francisco, CA. Hosted by BioIVT, home to the Center for NeuroExcellence, this symposium will bring together leading researchers, drug developers, and industry professionals to explore cutting-edge advancements in neuroscience and biomarkers.
Featuring researchers from academia, industry, and BioIVT, this event will highlight breakthroughs in biomarker discovery and preclinical drug development in neurological diseases.
Target Audience:
- Drug developers interested in the latest advancements in biomarkers for neurodegenerative diseases
- Scientists and directors interested in overcoming challenges for CNS-targeting drugs
- Lab scientists, managers, and directors in biotech/pharma working on drug development in CNS diseases
Attendees will learn:
- The importance and application of biomarkers in neurodegenerative diseases, including how demographic factors influence biomarkers and the latest advances in blood biomarker tests.
- The challenges of developing CNS drugs and crossing the blood-brain barrier, with a focus on the pivotal role of transporters.
- The latest breakthroughs and innovative therapies in drug development for neurodegenerative diseases such as ALS and Alzheimer’s disease.
- Cutting-edge research on Alzheimer’s disease, from uncovering key pathology drivers and biomarkers to advancing therapeutic innovation.
Registration is required to attend.
Agenda: June 25
Translating Diversity and Longitudinal Data into Discovery
Speakers: Courtney Noah, PhD, BioIVT
Blood Biomarkers in Alzheimer’s: Transforming Brain Health Through Precision Medicine
Speakers: Philip Verghese, PhD, C2N Diagnostics
Leveraging MS-Based Proteomics to Drive Biomarker Discovery
Speakers: Christian Cizek, Biognosys
Lunch
Restoring UNC13A as a treatment for people with ALS
Speakers: Georgiana Miller, PhD, Trace Neuroscience
Coffee Break
Speakers: Sheng Zhong, PhD, University of California, San Diego
Panel Discussion
Hosted by: Tina Mueller with panelists Courtney Noah, Philip Verghese, Christian Cizek, Mark Warren, and Sheng Zhong
Happy Hour and Networking
Speaker: Dr. Tina Mueller, Scientific Advisor, ADMET Services, BioIVT
Abstract: There is renewed interest in developing psychedelics such as psilocybin,
The Lighthouse Cafe
The event will be held at The Lighthouse Cafe & Conference Center: 685 Gateway Boulevard, South San Francisco, CA, 94080.
Resources

BioIVT has been the leading provider of ADME products for more than 25 years. In that time, we have isolated hepatocytes from several thousand human livers and continue to add several hundred new lots each year.

BioIVT provides ADME / DMPK services including consulting on ADME strategies, design and implementation of in vitro and in vivo studies, bioanalysis, analysis of study data, and report development.

Learn more about ADME Consulting Services at BioIVT. Our experts help researchers optimize in vitro research programs and ensure data packages are ready for regulatory submissions.